Stocktoria
Lexeo Therapeutics, Inc. LXEO
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2023-11-03
Lexeo Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| CITADEL ADVISORS LLC | 3,845,699 | $22.1M | 5.27% |
| BlackRock Finance, Inc. | 791,584 | $12.7M | 1.08% |
| Point72 Asset Management, L.P. | 1,680,449 | $9.6M | 2.3% |
| MILLENNIUM MANAGEMENT LLC | 1,612,780 | $9.3M | 2.21% |
| AQR CAPITAL MANAGEMENT LLC | 339,623 | $1.9M | 0.47% |
| TWO SIGMA INVESTMENTS, LP | 181,676 | $1.0M | 0.25% |
| D. E. Shaw & Co., Inc. | 30,477 | $174,938 | 0.04% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.